Oligonucleotide Molecular Sprinkler for Intracellular Detection and Spontaneous Regulation of mRNA for Theranostics of Scar Fibroblasts

Early diagnosis and timely intervention are key for the successful treatment of skin diseases like abnormal scars. This study introduces a nucleic‐acid‐based probe (i.e., molecular sprinkler) for the diagnosis and spontaneous regulation of the abnormal expression of fibrosis‐related mRNA in scar‐der...

Full description

Saved in:
Bibliographic Details
Published in:Small (Weinheim an der Bergstrasse, Germany) Germany), 2018-12, Vol.14 (49), p.e1802546-n/a
Main Authors: Zheng, Mengjia, Wiraja, Christian, Yeo, David C., Chang, Hao, Lio, Daniel Chin Shiuan, Shi, Wei, Pu, Kanyi, Paller, Amy S., Xu, Chenjie
Format: Article
Language:English
Subjects:
abnormal fibroblast
Connective tissues
Diagnosis
Fibroblasts
Fibrosis
Gene expression
Growth factors
mRNA
Nanotechnology
oligonucleotide sensors
Oligonucleotides
Scars
Skin
skin disease
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Early diagnosis and timely intervention are key for the successful treatment of skin diseases like abnormal scars. This study introduces a nucleic‐acid‐based probe (i.e., molecular sprinkler) for the diagnosis and spontaneous regulation of the abnormal expression of fibrosis‐related mRNA in scar‐derived skin fibroblasts. Using mRNA encoding connective tissue growth factor (CTGF) as the model gene, a probe with three oligonucleotides is constructed, including a recognition sequence complementary to the CTGF mRNA, a siRNA against transforming growth factor receptor I (TGFβRI) as the CTGF mRNA suppressor, and a connecting sequence. The probe can detect CTGF mRNA with a limit of 10 × 10−9 m and distinguishes scar fibroblasts from normal ones in both 2D and 3D environments. Two days after transfection, the siRNA released from the probe reduces the expression of TGFβRI and, consequently, decreases the cellular expression of CTGF mRNA (up to 70%). This dual‐role probe presents opportunities to monitor the TGF‐ β signaling pathway, screen for drugs that target the CTGF pathway, and determine the role of inhibition of the CTGF pathway in therapeutic efficacy. A nucleic‐acid‐based probe for the diagnosis and spontaneous regulation of the fibrosis‐related mRNA in scar‐derived skin fibroblasts is developed. It distinguishes scar fibroblasts from normal ones in both 2D and 3D environments. Two days after transfection, the siRNA released from the probe reduces the expression of TGFβRI and decreases the cellular expression of CTGF mRNA (70%).
ISSN:1613-6810
1613-6829
DOI:10.1002/smll.201802546